Skip Navigation



JAC Advance Access published online on January 3, 2008

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm479
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
61/2/341    most recent
dkm479v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pag, U.
Right arrow Articles by Sahl, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pag, U.
Right arrow Articles by Sahl, H.-G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an {alpha}-helical ‘sequence template’

U. Pag1, M. Oedenkoven1, V. Sass1, Y. Shai2, O. Shamova3, N. Antcheva4, A. Tossi4 and H.-G. Sahl1,*

1 Institute for Medical Microbiology, Immunology and Parasitology—Pharmaceutical Microbiology Section, University of Bonn, 53105 Bonn, Germany 2 Department of Biological Chemistry, The Weizmann Institute of Science, 76100 Rehovot, Israel 3 Institute for Experimental Medicine of the Russian Academy of Medical Sciences, 197376 St Petersburg, Russian Federation 4 Department of Biochemistry, Biophysics and Macromolecular Chemistry, University of Trieste, 34127 Trieste, Italy

Received 16 August 2007; returned 10 October 2007; revised 16 November 2007; accepted 18 November 2007


* Corresponding author. Tel: +49-228-73-5272; Fax: +49-228-73-5267; E-mail: sahl{at}mibi03.meb.uni-bonn.de

Objectives: Cationic antimicrobial peptides (AMPs) are indispensable components of innate immune systems and promising candidates for novel anti-infective strategies. We rationally designed a series of peptides based on a template derived from known {alpha}-helical AMPs, which were then analysed regarding efficacy against clinical isolates and antibiotic mechanisms.

Methods: Efficacy tests included standard MIC and synergy assays. Whole cell assays with staphylococcal strains included killing kinetics, efflux experiments and determination of membrane depolarization. The transcriptional response of AMP-treated Staphylococcus aureus SG511 was analysed using a Scienion genomic microarray covering (~90% of) the S. aureus N315 genome and AMP P16(6|E).

Results: The AMPs showed remarkable broad-spectrum activity against bacteria and fungi regardless of any pre-existing antibiotic resistance mechanism. Whole cell assays indicated that the AMPs target the cytoplasmic membrane; however, significant membrane leakage and depolarization was only observed with a standard laboratory test strain. Transcriptional profiling identified up-regulation of putative efflux pumps and of aerobic energy generation mechanisms as major counter activities. Important components of the staphylococcal cell wall stress stimulon were up-regulated and the lipid metabolism was also affected.

Conclusions: The broad spectrum activity of amphiphilic helical AMPs is based on multiple stresses resulting from interactions with microbial membranes; however, rather than killing through formation of pores, the AMPs appear to interfere with the coordinated and highly dynamic functioning of membrane bound multienzyme complexes such as electron transport chains and cell wall or lipid biosynthesis machineries.

Key Words: membrane permeabilization , intracellular targets , transcriptional profiling , microarray


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Q. Do, S. Moshkani, P. Castillo, S. Anunta, A. Pogosyan, A. Cheung, B. Marbois, K. F. Faull, W. Ernst, S. M. Chiang, et al.
Lipids Including Cholesteryl Linoleate and Cholesteryl Arachidonate Contribute to the Inherent Antibacterial Activity of Human Nasal Fluid
J. Immunol., September 15, 2008; 181(6): 4177 - 4187.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
D. Raafat, K. von Bargen, A. Haas, and H.-G. Sahl
Insights into the Mode of Action of Chitosan as an Antibacterial Compound
Appl. Envir. Microbiol., June 15, 2008; 74(12): 3764 - 3773.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.